Virtuix Holdings Inc. VTIX Issuance of warrants to purchase common stock

Issuance of warrants to purchase common stock at other companies

Ispire Technology Inc.ISPR

$91.49K—

Envoy MedicalCOCH

$882K+348%

CO2 Energy Transition Corp. Common StockNOEM

$51.75K—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

ADMA BiologicsADMA

$1.4M—

Evommune EVMN

$150—

Other financials

Income statement

See full

Revenue$1.3M-14.0%

Gross profit$173.6K—

Operating income-$4.9M-98.1%

Net income-$9.9M-277%

EPS (diluted)-$0.39-21.9%

Balance sheet

See full

Cash & equivalents$9.5M+1,882%

Total debt$3.2M+273%

Total equity$3.0M+484%

Total assets$14.8M+156%

Cash flow

See full

Operating cash flow-$4.0M-156%

Valuation

See full

Market cap$100.34M-69.9%

Enterprise value$94.08M—

P/S20.2×—

Profitability

See full

Gross margin11.5%—

Operating margin-221.9%—

Net margin-337.4%—

Returns & leverage

See full

Return on equity-1,490.6%—

Debt / equity1.1×—

Current ratio1.4×+1.0×

Where this comes from

Reported directly by Virtuix Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: Virtuix Holdings Inc. ’s 10-Q, filed March 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Virtuix Holdings Inc. 's issuance of warrants to purchase common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Virtuix Holdings Inc. 's issuance of warrants to purchase common stock?: Virtuix Holdings Inc. (VTIX) reported issuance of warrants to purchase common stock of $717.95K in Q4 2025.